Search
01/01/2023
Surgical and oncological results after surgical treatment of patients diagnosed with sarcoma liver metastases
González-Abós S., Molina Santos V., Homs Samsó R., Martín Arnau B., Rodríguez Blanco M., González López J.A., López-Pousa A., Moral Duarte A., Sánchez-Cabús S.. Surgical and oncological results after surgical treatment of patients diagnosed with sarcoma liver metastases. CIRUGIA ESPANOLA. 2023; 101(2)DOI:10.1016/j.ciresp.2021.11.005. PMID:35901963. IF:1.300(Q3/7D).
01/01/2023
Our experience in the short-term diagnostic-therapeutic management of the patient with anal dysplasia
Galán Martínez C., Hernández Casanovas M.P., Sala Vilaplana L., Sánchez López A., Martínez Sánchez M.C., Bollo Rodríguez J., Pareja Nieto E., Targarona Soler E.M.. Our experience in the short-term diagnostic-therapeutic management of the patient with anal dysplasia. CIRUGIA ESPANOLA. 2023; 101(3)DOI:10.1016/j.ciresp.2022.03.010. PMID:36152962. IF:1.300(Q3/7D).
01/01/2023
Short-term outcomes of chemoradiotherapy and local excision versus total mesorectal excision in T2-T3ab,N0,M0 rectal cancer: a multicentre randomised, controlled, phase III trial (the TAU-TEM study)
Serra-Aracil X., Pericay C., Badia-Closa J., Golda T., Biondo S., Hernández P., Targarona E., Borda-Arrizabalaga N., Reina A., Delgado S., Vallribera F., Caro A., Gallego-Plazas J., Pascual M., Álvarez-Laso C., Guadalajara-Labajo H.G., Mora-Lopez L.. Short-term outcomes of chemoradiotherapy and local excision versus total mesorectal excision in T2-T3ab,N0,M0 rectal cancer: a multicentre randomised, controlled, phase III trial (the TAU-TEM study). ANNALS OF ONCOLOGY. 2023; 34(1)DOI:10.1016/j.annonc.2022.09.160. PMID:36220461. IF:56.700(Q1/1D).
01/01/2023
Hiatoplasty with running barbed suture: An alternative to conventional hiatal closure
Sala L., Fernández-Ananín S., Pérez N., M. Targarona E.. Hiatoplasty with running barbed suture: An alternative to conventional hiatal closure. CIRUGIA ESPANOLA. 2023; 101(6)DOI:10.1016/j.ciresp.2022.12.009. PMID:36948416. IF:1.300(Q3/7D).
01/01/2023
Mammary-like gland perianal adenocarcinoma.
Pareja Nieto E, Bollo Rodríguez J, Hernández Casanovas MP, Galán Martínez C, Targarona Soler EM. Mammary-like gland perianal adenocarcinoma.. CIRUGIA ESPANOLA. 2023; 101(1)DOI:10.1016/j.cireng.2022.06.046. PMID:35787474. IF:(Q/D).
01/01/2023
Gastroesophageal reflux after sleeve gastrectomy: The dimension of the problem
Fernández-Ananín S., Balagué Ponz C., Sala L., Molera A., Ballester E., Gonzalo B., Pérez N., Targarona E.M.. Gastroesophageal reflux after sleeve gastrectomy: The dimension of the problem. CIRUGIA ESPANOLA. 2023; 101DOI:10.1016/j.ciresp.2023.05.009. PMID:37952718. IF:1.300(Q3/7D).
01/01/2023
Correlación de la inactivación del cromosoma X con la presentación clínica de la enfermedad de Fabry a propósito de un caso
Rodríguez Doyágüez P., Furlano M., Ars Criach E., Arce Y., Guirado L., Torra Balcells R.. Correlación de la inactivación del cromosoma X con la presentación clínica de la enfermedad de Fabry a propósito de un caso. NEFROLOGIA. 2023; 43DOI:10.1016/j.nefro.2022.12.001. PMID:. IF:(Q/D).
01/01/2023
Why do we keep ignoring sex in kidney disease?
Jankowska M., JoséSoler M., Stevens K.I., Torra R.. Why do we keep ignoring sex in kidney disease?. Clinical Kidney Journal. 2023; 16(12)DOI:10.1093/ckj/sfad183. PMID:. IF:(Q/D).